# Celldex Therapeutics, Inc (CLDX)

Celldex Therapeutics (CLDX) is featured in a Q1 [----] biotech catalyst watchlist, highlighting its Phase [--] readouts. This comes amidst significant social media buzz and positive analyst sentiment.

### About Celldex Therapeutics, Inc
Celldex Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for cancer and other diseases.  
Celldex Therapeutics, Inc uses the ticker $CLDX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Celldex Therapeutics, Inc (CLDX) social dominance is up 100% from the previous week.
- Celldex Therapeutics, Inc (CLDX) Galaxy Score™ is up 22.22% from the previous week.
- Celldex Therapeutics, Inc (CLDX) creators is up 32% from the previous week.
- Celldex Therapeutics, Inc (CLDX) engagements is up 233.11% from the previous month.
- Celldex Therapeutics, Inc (CLDX) mentions is up 11.9% from the previous week.
- Celldex Therapeutics, Inc (CLDX) posts created is up 25% from the previous week.

### Price: $23
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/close.tsv)  
The stock's price action is bullish, reaching a 52-week high due to positive trial data and analyst upgrades, as evidenced by the 16.78% gain over the past [--] days. However, concerns about recent net losses and price volatility are tempering this upward trend, reflected in the 24-hour gain of -1.24%.  

24-Hour: -2.42%
7-Day: -3.2%
30-Day: -10.33%

1-Year High: $29.80 on 2025-12-08  
1-Year Low: $15.10 on 2025-04-08  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/alt_rank.tsv)  
Celldex Therapeutics, Inc (CLDX) is currently AltRank #1,792 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +122  
[--] Month: [-----] +746  
[--] Months: [-----] +678  
[--] Year: [-----] +133  
1-Year High: [-----] on 2026-02-11  
1-Year Low: [---] on 2025-12-21  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +6  
[--] Month: [--] [---]  
[--] Months: [--] +5  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-04-11  
1-Year Low: [--] on 2025-12-26  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [------] +29%  
[--] Month: [-------] +233%  
[--] Months: [-------] -1.60%  
[--] Year: [---------] -13%  
1-Year High: [-------] on 2025-08-20  
1-Year Low: [--] on 2025-04-13  

Engagements by network (24h):
Reddit: [--]
X: [-----]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] +12%  
[--] Month: [---] +6.10%  
[--] Months: [-----] -28%  
[--] Year: [-----] +26%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-04-13  

Mentions by network (24h):
Reddit: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Celldex Therapeutics, Inc (CLDX) in the last [--] hours which is up 46% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +32%  
[--] Month: [--] -17%  
[--] Months: [---] -54%  
[--] Year: [-----] +61%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-04-13  

The most influential creators that mention Celldex Therapeutics, Inc in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [-----]       |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [---]         |
| [@ParadiseTraderr](/creator/twitter/ParadiseTraderr) | [--]    | [---]       | [--]     | [--]          |
| [@Fredbenz0](/creator/twitter/Fredbenz0)             | [--]    | [-----]     | [--]     | [--]          |
| [@SMALLCAPSAXIS](/creator/twitter/SMALLCAPSAXIS)     | [--]    | [---]       | [--]     | [--]          |
| [@TheOptionsBull2](/creator/twitter/TheOptionsBull2) | [--]    | [---]       | [--]     | [--]          |

[View More](/list/creators/$cldx/100)
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 78%  
[--] Week: 100% no change  
[--] Month: 100% no change  
[--] Months: 100% +35%  
[--] Year: 100% +33%  
1-Year High: 100% on 2025-02-26  
1-Year Low: 13% on 2025-11-29  

Most Supportive Themes:
- Positive Trial Data: (40%) Recent positive trial data has been a significant driver for Celldex Therapeutics, boosting investor confidence and contributing to the stock's upward trend.
- Analyst Upgrades: (30%) Upgrades from financial analysts have further bolstered the positive sentiment surrounding Celldex Therapeutics, influencing its current market performance.
  
Most Critical Themes:
- Net Losses: (20%) Despite positive developments, Celldex Therapeutics has reported recent net losses, which are a point of concern for investors and may temper the stock's rally.
- Price Volatility: (10%) The stock has experienced notable price volatility, a factor that could introduce risk for investors and influence short-term trading strategies.
  
  
  
### Social Dominance: 0.00239%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/social_dominance.tsv)  
Current Value: 0.00239%  
Daily Average: 0.00652%  
[--] Week: 0.0036% +0.0018%  
[--] Month: 0.0038% +0.0007000000000000001%  
[--] Months: 0.0038% -0.0056%  
[--] Year: 0.0038% -0.0046%  
1-Year High: 0.034% on 2025-06-29  
1-Year Low: 0.001% on 2025-12-25  
  
  
### Market Dominance: 0.00173%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/market_dominance.tsv)  
Current Value: 0.00173%  
Daily Average: 0%  
1-Year High: 0.045% on 2025-03-31  
1-Year Low: 0.00166% on 2025-04-09  
  
  
### Market Cap: $1,528,337,833
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/market_cap.tsv)  
Current Value: $1,528,337,833  
Daily Average: $1,532,857,463  
[--] Week: $1,528,337,833 -3.20%  
[--] Month: $1,528,337,833 -10%  
[--] Months: $1,528,337,833 -6%  
[--] Year: $1,528,337,833 +1.50%  
1-Year High: $1,980,194,236 on 2025-12-08  
1-Year Low: $1,004,387,060 on 2025-04-08  

### Top Celldex Therapeutics, Inc Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA"  
[X Link](https://x.com/BiopharmIQ/status/2020573160345940394) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-08T18:59Z 28.9K followers, [----] engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $KOD Phase 2b $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $BFRI Phase [--] $KPTI Phase [--] $IOVA Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $MLTX Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA Phase [--] $ARQT"  
[X Link](https://x.com/BiopharmIQ/status/2018051066605220000) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-01T19:57Z 28.9K followers, 112.2K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing